Skip to content

Shop BLIS Probiotics >

  • Solutions

    Probiotic Portfolio

    BLIS K12™

    BLIS M18™

    BLIS Q24™

    Health Areas

    ENT Health

    Immune Health

    Dental Health

    Skin Health

    Finished Goods

    BLIS Q24™ Live Probiotic Serum

    BLIS K12™ Throat Health Lozenge

    BLIS K12™ Immunity Lozenge

    BLIS K12™ Immunity Kids Powder

    BLIS K12™ Fresh Breath Lozenge

    BLIS M18™ Teeth & Gums Lozenge

  • Work With Us

    Private Label

    Ingredients

    R&D and Formulations

  • Research

    Clinical Studies

    Scientific Collaboration

  • Investor Centre

    NZX Announcements

    Annual & Half Year Reports

    Corporate Governance

    Charters & Policies

    FAQs

    Key Dates

    Investor Enquiries

  • Company

    Our Mission

    Our Story

    Facilities

    Partners

  • Knowledge

    Press

    Awards

    White Papers

    Events

CONTACT US
CONTACT US

Scientific collaboration

Join us in our mission to improve health through the power of probiotics.

Probiotic Scientific Research
Throat Oral Microbiome

Learn With Us

As leaders in oral probiotics, we recognise the importance of research in shaping new product development. We collaborate with leading universities and academics across New Zealand, and globally, on joint research projects, clinical trials and academic partnerships.

John Hale

Chief Technology Officer ENQUIRE NOW

Pioneering Probiotic Health

BLIS K12 supports oral health in children

New study on BLIS K12 probiotic supports oral hygiene benefits in children

Science continues to build supporting Stratum Nutrition and Blis Technologies’ BLIS K12™ probiotic strain and its oral hygiene benefits. This latest study focuses on children with bad breath.

Read More
Probiotics Study on Covid-19

Studies Investigate Probiotic Impact on COVID-19

Three independent global studies showed positive reduction against COVID-19 and upper respiratory illnesses when consuming BLIS K12™, according to a press release from Blis Technologies.

Read More
BLIS K12 study

Probiotic BLIS K12 Defends Against Variety of Oral Infections in Children, Study Suggests

BLIS K12, an oral-health probiotic made from the strain Streptococcus salivarius K12™, has shown benefits in past studies at reducing incidence of streptococcal pharyngitis in children and adults. 

Read More

Solutions

  • Probiotic Portfolio
  • Health Areas
  • Finished Goods

WORK WITH US

  • Ingredients
  • Private Label
  • R&D and Formulations

Other Links

  • Investor Centre
  • Privacy Policy
  • Terms & Conditions
  • Terms of Trade

Connect With Us

  • @blis-technologies-limited
    @blis-technologies-limited
  • Info@blis.co.nz
    Info@blis.co.nz
  • Buy BLIS Probiotics Online:
BlisProbiotics.co.NZ

© 2023 Blis Technologies ·
Website crafted by Drive Digital